Editorials Drugs for Alzheimer's disease BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7305.123 (Published 21 July 2001) Cite this as: BMJ 2001;323:123 Article Related content Metrics Responses Peer review Related articles Review The hazards of good memory Published: 14 April 2005; BMJ 330 doi:10.1136/bmj.330.7496.913 Letter Drugs for Alzheimer's disease Published: 10 November 2001; BMJ 323 doi:10.1136/bmj.323.7321.1127/a Analysis And Comment Role of cholinesterase inhibitors in dementia care needs rethinking Published: 31 August 2006; BMJ 333 doi:10.1136/bmj.38945.478160.94 See more Individual care plans reduce falls and broken hips in New Zealand hospitals BMJ December 05, 2016, 355 i6490; DOI: https://doi.org/10.1136/bmj.i6490 One in three with mild cognitive impairment has depression, review finds BMJ November 28, 2016, 355 i6387; DOI: https://doi.org/10.1136/bmj.i6387 Clinical commissioning groups will be rated on sepsis care BMJ November 25, 2016, 355 i6361; DOI: https://doi.org/10.1136/bmj.i6361 GPs award potential £700m contract to Virgin Care BMJ November 14, 2016, 355 i6130; DOI: https://doi.org/10.1136/bmj.i6130 Manufacturers tell FDA why they should be able to promote drugs and devices off label BMJ November 14, 2016, 355 i6098; DOI: https://doi.org/10.1136/bmj.i6098 Cited by... Role of cholinesterase inhibitors in dementia care needs rethinkingFulltext PDF Has the referral of older adults with dementia changed since the availability of acetylcholinesterase inhibitors and the NICE guidelines?Fulltext PDF Abstract Evaluation of the safety and immunogenicity of synthetic A{beta}42 (AN1792) in patients with ADFulltext PDF Abstract A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's diseaseFulltext PDF Abstract Managing Alzheimer Dementia TomorrowFulltext PDF Abstract Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementiaFulltext PDF Abstract